Obstetrics & Gynecology in Blue Bell, PA
9 verified obstetrics & gynecology doctors in Blue Bell.
OB/GYNs provide women's reproductive health care, including pregnancy, childbirth, and gynecologic conditions.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Pennsylvania State Board of Medicine
Dr. Jeffrey Blatt, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Erik Smith, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Andres Ramos, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Paul Neumann, MD
Obstetrics & Gynecology
CMS Open Payments· $242.23 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$242.23
Total received
13
Transactions
8
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Paul Neumann do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Fitzgerald, DO
Obstetrics & Gynecology
CMS Open Payments· $94.50 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$94.50
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 69th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to John Fitzgerald do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Thea Cooper Barton, DO
Obstetrics & Gynecology
CMS Open Payments· $310.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$310.14
Total received
21
Transactions
7
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Thea Cooper Barton do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jess Omana, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Stephanie Osawaru, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Nicole Cumbo, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.